Journal of Clinical Oncology, Vol 15, 2345-2350, Copyright © 1997 by American Society of Clinical Oncology
Sentinel lymphadenectomy in breast cancer
AE Giuliano, RC Jones, M Brennan and R Statman
Joyce Eisenberg Keefer Breast Center, John Wayne Cancer Institute at Saint John's Health Center, Santa Monica, CA 90404, USA.
PURPOSE: We previously demonstrated increased detection of axillary
metastases using sentinel lymphadenectomy (SLND) and immunohistochemistry.
These methods have evolved and we now report our current use of these
techniques and our most recent results of axillary staging with SLND.
PATIENTS AND METHODS: One hundred seven consecutive women (previously
unreported) with breast cancer underwent SLND followed by completion
axillary lymphadenectomy (ALND). All sentinel nodes were examined
intraoperatively with frozen section and postoperatively with hematoxylin
and eosin staining (H&E) plus immunohistochemical staining (IHC) using
antibody to cytokeratin. The nonsentinel axillary nodes were examined with
H&E, but not IHC. RESULTS: The median age was 56.6 years (range, 28 to
90). Most patients (58.9%) were postmenopausal, most primary tumors (62.6%)
were palpable, and most operations (86.9%) were breast-conserving. The mean
tumor size was 2.11 +/- 1.38 cm. Sentinel nodes were identified in 100
patients: 42 patients had metastases in sentinel nodes; of these, 28
(66.7%) had no other involved axillary nodes. On average, 1.8 +/- 1.1
sentinel nodes were examined and 20.3 +/- 7.8 nonsentinel nodes were
removed. Of seven patients with no identified sentinel nodes, six had a
tumor- negative axilla. SLND was 100% predictive of axillary status in
these 100 women. CONCLUSION: In this population of breast cancer patients,
SLND with frozen section and IHC was a minimally invasive, highly accurate
intraoperative method of axillary staging. We are evaluating the
elimination of routine ALND for sentinel-node negative women to minimize
the morbidity associated with standard dissections. The ability to identify
node-negative patients without ALND would be a welcome addition to the
management of women with breast cancer.
This article has been cited by other articles:

|
 |

|
 |
 
J. Cho, W. Han, J. W. Lee, E. Ko, S. Y. Kang, S.-Y. Jung, E.-K. Kim, W. K. Moon, N. Cho, I.-A. Park, et al.
A Scoring System to Predict Nonsentinel Lymph Node Status in Breast Cancer Patients with Metastatic Sentinel Lymph Nodes: A Comparison with Other Scoring Systems
Ann. Surg. Oncol.,
August 1, 2008;
15(8):
2278 - 2286.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
I. Miyashiro, N. Miyoshi, M. Hiratsuka, K. Kishi, T. Yamada, M. Ohue, H. Ohigashi, M. Yano, O. Ishikawa, and S. Imaoka
Detection of Sentinel Node in Gastric Cancer Surgery by Indocyanine Green Fluorescence Imaging: Comparison with Infrared Imaging
Ann. Surg. Oncol.,
June 1, 2008;
15(6):
1640 - 1643.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Medina-Franco, S. Soto-Germes, J. L. Ulloa-Gomez, C. Romero-Trejo, N. Uribe, C. A. Ramirez-Alvarado, and C. Robles-Vidal
Radiofrequency Ablation of Invasive Breast Carcinomas: A Phase II Trial
Ann. Surg. Oncol.,
June 1, 2008;
15(6):
1689 - 1695.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Alran, Y. De Rycke, V. Fourchotte, H. Charitansky, F. Laki, M. C. Falcou, M. Benamor, P. Freneaux, R. J. Salmon, for the Institut Curie Breast Cancer Study Group, et al.
Validation and Limitations of Use of a Breast Cancer Nomogram Predicting the Likelihood of Non Sentinel Node Involvement After Positive Sentinel Node Biopsy
Ann. Surg. Oncol.,
August 1, 2007;
14(8):
2195 - 2201.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. M. Layman, D. G. Thomas, K. A. Griffith, J. B. Smerage, M. A. Helvie, M. A. Roubidoux, K. M. Diehl, L. A. Newman, M. S. Sabel, J. A. Hayman, et al.
Neoadjuvant Docetaxel and Capecitabine and the Use of Thymidine Phosphorylase as a Predictive Biomarker in Breast Cancer
Clin. Cancer Res.,
July 15, 2007;
13(14):
4092 - 4097.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakagawa, S. R. Martinez, Y. Goto, K. Koyanagi, M. Kitago, T. Shingai, D. A. Elashoff, X. Ye, F. R. Singer, A. E. Giuliano, et al.
Detection of Circulating Tumor Cells in Early-Stage Breast Cancer Metastasis to Axillary Lymph Nodes
Clin. Cancer Res.,
July 15, 2007;
13(14):
4105 - 4110.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. D. Nathanson, J. K. Grogan, D. DeBruyn, A. Kapke, and K. Karvelis
Breast Cancer Sentinel Lymph Node Identification Rates: The Influence of Radiocolloid Mapping, Case Volume, and the Place of the Procedure
Ann. Surg. Oncol.,
May 1, 2007;
14(5):
1629 - 1637.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. P. Khatri, J. P. McGahan, R. Ramsamooj, S. Griffey, J. Brock, M. Cronan, and S. Wilkendorf
A Phase II Trial of Image-Guided Radiofrequency Ablation of Small Invasive Breast Carcinomas: Use of Saline-Cooled Tip Electrode
Ann. Surg. Oncol.,
May 1, 2007;
14(5):
1644 - 1652.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. E. Dauphine, J. S. Haukoos, M. P. Vargas, N. M. Isaac, I. Khalkhali, and H. I. Vargas
Evaluation of Three Scoring Systems Predicting Non Sentinel Node Metastasis in Breast Cancer Patients with a Positive Sentinel Node Biopsy
Ann. Surg. Oncol.,
March 1, 2007;
14(3):
1014 - 1019.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J.-C. Yu, G.-C. Hsu, C.-B. Hsieh, C.-P. Yu, and T.-Y. Chao
Role of Sentinel Lymphadenectomy Combined with Intraoperative Ultrasound in the Assessment of Locally Advanced Breast Cancer After Neoadjuvant Chemotherapy
Ann. Surg. Oncol.,
January 1, 2007;
14(1):
174 - 180.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Nakagawa, S. K. Huang, S. R. Martinez, A. N. Tran, D. Elashoff, X. Ye, R. R. Turner, A. E. Giuliano, and D. S.B. Hoon
Proteomic Profiling of Primary Breast Cancer Predicts Axillary Lymph Node Metastasis
Cancer Res.,
December 15, 2006;
66(24):
11825 - 11830.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Chen, D. M. Iddings, R. P. Scheri, and A. J. Bilchik
Lymphatic Mapping and Sentinel Node Analysis: Current Concepts and Applications
CA Cancer J Clin,
September 1, 2006;
56(5):
292 - 309.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Motomura, C. Egawa, Y. Komoike, S. Nagumo, H. Koyama, and H. Inaji
Three-Axillary Lymph Node Sampling for the Prediction of Nonsentinel Node Metastases in Breast Cancer Patients With Sentinel Node Metastases
Ann. Surg. Oncol.,
July 1, 2006;
13(7):
985 - 989.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. L. Allan, R. George, S. A. Vantyghem, M. W. Lee, N. C. Hodgson, C. J. Engel, R. L. Holliday, D. P. Girvan, L. A. Scott, C. O. Postenka, et al.
Role of the Integrin-Binding Protein Osteopontin in Lymphatic Metastasis of Breast Cancer
Am. J. Pathol.,
July 1, 2006;
169(1):
233 - 246.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G.-C. Hsu, C.-H. Ku, J.-C. Yu, C.-B. Hsieh, C.-P. Yu, and T.-Y. Chao
Application of intraoperative ultrasound to nonsentinel node assessment in primary breast cancer.
Clin. Cancer Res.,
June 15, 2006;
12(12):
3746 - 3753.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. C. Snider Jr., E. Rubin, and R. Henson
Axillary Ultrasonography to Detect Recurrence After Sentinel Node Biopsy in Breast Cancer
Ann. Surg. Oncol.,
April 1, 2006;
13(4):
501 - 507.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. A. Lambert, G. D. Ayers, R. F. Hwang, K. K. Hunt, M. I. Ross, H. M. Kuerer, S. E. Singletary, G. V. Babiera, F. C. Ames, B. Feig, et al.
Validation of a Breast Cancer Nomogram for Predicting Nonsentinel Lymph Node Metastases After a Positive Sentinel Node Biopsy
Ann. Surg. Oncol.,
March 1, 2006;
13(3):
310 - 320.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Uren
Sentinel Lymph Node Biopsy in Melanoma
J. Nucl. Med.,
February 1, 2006;
47(2):
191 - 195.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. K. Rivers, K. A. Griffith, K. K. Hunt, A. C. Degnim, M. S. Sabel, K. M. Diehl, V. M. Cimmino, A. E. Chang, P. C. Lucas, and L. A. Newman
Clinicopathologic Features Associated With Having Four or More Metastatic Axillary Nodes in Breast Cancer Patients With a Positive Sentinel Lymph Node
Ann. Surg. Oncol.,
January 1, 2006;
13(1):
36 - 44.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. Suga, K. Shimizu, Y. Kawakami, A. Tangoku, M. Zaki, N. Matsunaga, and M. Oka
Lymphatic Drainage from Esophagogastric Tract: Feasibility of Endoscopic CT Lymphography for Direct Visualization of Pathways
Radiology,
December 1, 2005;
237(3):
952 - 960.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. H. Lyman, A. E. Giuliano, M. R. Somerfield, A. B. Benson III, D. C. Bodurka, H. J. Burstein, A. J. Cochran, H. S. Cody III, S. B. Edge, S. Galper, et al.
American Society of Clinical Oncology Guideline Recommendations for Sentinel Lymph Node Biopsy in Early-Stage Breast Cancer
J. Clin. Oncol.,
October 20, 2005;
23(30):
7703 - 7720.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. C. Degnim, K. Oh, V. M. Cimmino, K. M. Diehl, A. E. Chang, L. A. Newman, and M. S. Sabel
Is Blue Dye Indicated for Sentinel Lymph Node Biopsy in Breast Cancer Patients With a Positive Lymphoscintigram?
Ann. Surg. Oncol.,
September 1, 2005;
12(9):
712 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Mamounas, A. Brown, S. Anderson, R. Smith, T. Julian, B. Miller, H. D. Bear, C. B. Caldwell, A. P. Walker, W. M. Mikkelson, et al.
Sentinel Node Biopsy After Neoadjuvant Chemotherapy in Breast Cancer: Results From National Surgical Adjuvant Breast and Bowel Project Protocol B-27
J. Clin. Oncol.,
April 20, 2005;
23(12):
2694 - 2702.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. G. Zogakis, R. E. Wetherille, R. D. Christensen, K. J. Ose, J. D. Friedman, M. Colbert, C. A. Svendsen, O. K. Sanan, and T. M. Tuttle
Intraoperative Subareolar Injection of 99mTc-Labeled Sulfur Colloid Results in Consistent Sentinel Lymph Node Identification
Ann. Surg. Oncol.,
February 1, 2005;
12(2):
167 - 172.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
P. Z. Israel
"Axillary Recurrence After a Negative Sentinel Node Biopsy": Editorial Comment
Ann. Surg. Oncol.,
January 1, 2005;
12(1):
9 - 9.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. L. Smidt, C. M. M. Janssen, D. M. Kuster, E. D. M. Bruggink, and L. J. A. Strobbe
Axillary Recurrence After a Negative Sentinel Node Biopsy for Breast Cancer: Incidence and Clinical Significance
Ann. Surg. Oncol.,
January 1, 2005;
12(1):
29 - 33.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. J. Gray, B. A. Pockaj, and C. R. Conley
Sentinel Lymph Node Metastases Detected by Immunohistochemistry Only Do Not Mandate Complete Axillary Lymph Node Dissection in Breast Cancer
Ann. Surg. Oncol.,
December 1, 2004;
11(12):
1056 - 1060.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Fortunato, M. Amini, M. Farina, S. Rapacchietta, L. Costarelli, F. R. Piro, G. Alessi, P. Pompili, S. Bianca, and C. E. Vitelli
Intraoperative Examination of Sentinel Nodes in Breast Cancer: Is the Glass Half Full or Half Empty?
Ann. Surg. Oncol.,
November 1, 2004;
11(11):
1005 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N Lamichhane, K W Shen, C L Li, Q X Han, Y J Zhang, Z M Shao, and Z Z Shen
Sentinel lymph node biopsy in breast cancer patients after overnight migration of radiolabelled sulphur colloid
Postgrad. Med. J.,
September 1, 2004;
80(947):
546 - 550.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Kobayashi, S. Kawamoto, Y. Sakai, P. L. Choyke, R. A. Star, M. W. Brechbiel, N. Sato, Y. Tagaya, J. C. Morris, and T. A. Waldmann
Lymphatic Drainage Imaging of Breast Cancer in Mice by Micro-Magnetic Resonance Lymphangiography Using a Nano-Size Paramagnetic Contrast Agent
J Natl Cancer Inst,
May 5, 2004;
96(9):
703 - 708.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. Wada, S. Imoto, T. Hasebe, A. Ochiai, S. Ebihara, and N. Moriyama
Evaluation of Intraoperative Frozen Section Diagnosis of Sentinel Lymph Nodes in Breast Cancer
Jpn. J. Clin. Oncol.,
March 1, 2004;
34(3):
113 - 117.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. P. L. Leong
Paradigm of Metastasis for Melanoma and Breast Cancer Based on the Sentinel Lymph Node Experience
Ann. Surg. Oncol.,
March 1, 2004;
11(3_suppl):
192S - 197S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Torrenga, S. Meijer, H. Fabry, and J. van der Sijp
Sentinel Node Biopsy in Breast Cancer Patients: Triple Technique as a Routine Procedure
Ann. Surg. Oncol.,
March 1, 2004;
11(3_suppl):
231S - 235S.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. J. Van Zee, D.-M. E. Manasseh, J. L. B. Bevilacqua, S. K. Boolbol, J. V. Fey, L. K. Tan, P. I. Borgen, H. S. Cody III, and M. W. Kattan
A Nomogram for Predicting the Likelihood of Additional Nodal Metastases in Breast Cancer Patients With a Positive Sentinel Node Biopsy
Ann. Surg. Oncol.,
December 1, 2003;
10(10):
1140 - 1151.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. B. Edge, J. C. Niland, M. A. Bookman, R. L. Theriault, R. Ottesen, E. Lepisto, and J. C. Weeks
Emergence of Sentinel Node Biopsy in Breast Cancer as Standard-of-Care in Academic Comprehensive Cancer Centers
J Natl Cancer Inst,
October 15, 2003;
95(20):
1514 - 1521.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. P. Mamounas
NSABP Breast Cancer Clinical Trials: Recent Results and Future Directions
Clin. Med. Res.,
October 1, 2003;
1(4):
309 - 326.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Guller, E. Nitzsche, H. Moch, and M. Zuber
Is Positron Emission Tomography an Accurate Non-invasive Alternative to Sentinel Lymph Node Biopsy in Breast Cancer Patients?
J Natl Cancer Inst,
July 16, 2003;
95(14):
1040 - 1043.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G. C. Balch, S. K. Mithani, K. R. Richards, R. D. Beauchamp, and M. C. Kelley
Lymphatic Mapping and Sentinel Lymphadenectomy After Preoperative Therapy for Stage II and III Breast Cancer
Ann. Surg. Oncol.,
July 1, 2003;
10(6):
616 - 621.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Nos, P. Freneaux, C. Louis-Sylvestre, J. S. Hurren, D. Heitz, X. Sastre-Garau, and K. B. Clough
Macroscopic Quality Control Improves the Reliability of Blue Dye-Only Sentinel Lymph Node Biopsy in Breast Cancer
Ann. Surg. Oncol.,
June 1, 2003;
10(5):
525 - 530.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. K. Blanchard, J. H. Donohue, C. Reynolds, and C. S. Grant
Relapse and Morbidity in Patients Undergoing Sentinel Lymph Node Biopsy Alone or With Axillary Dissection for Breast Cancer
Arch Surg,
May 1, 2003;
138(5):
482 - 488.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Simmons, S. Thevarajah, M. B. Brennan, P. Christos, and M. Osborne
Methylene Blue Dye as an Alternative to Isosulfan Blue Dye for Sentinel Lymph Node Localization
Ann. Surg. Oncol.,
April 1, 2003;
10(3):
242 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. F. Hwang, S. Krishnamurthy, K. K. Hunt, N. Mirza, F. C. Ames, B. Feig, H. M. Kuerer, S. E. Singletary, G. Babiera, F. Meric, et al.
Clinicopathologic Factors Predicting Involvement of Nonsentinel Axillary Nodes in Women With Breast Cancer
Ann. Surg. Oncol.,
April 1, 2003;
10(3):
248 - 254.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. S. Fant, M. D. Grant, S. M. Knox, S. A. Livingston, K. Ridl, R. C. Jones, and J. A. Kuhn
Preliminary Outcome Analysis in Patients With Breast Cancer and a Positive Sentinel Lymph Node Who Declined Axillary Dissection
Ann. Surg. Oncol.,
March 1, 2003;
10(2):
126 - 130.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Tamhane, J. E. Dahlstrom, D. D. McCallum, and J. M. Buckingham
The Clinical Significance of Cytokeratin-Positive Cells in Lymph Nodes at the Time of Mastectomy From Patients With Ductal Carcinoma-In-Situ
Ann. Surg. Oncol.,
December 1, 2002;
9(10):
999 - 1003.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
G Cserni
Complete sectioning of axillary sentinel nodes in patients with breast cancer. Analysis of two different step sectioning and immunohistochemistry protocols in 246 patients
J. Clin. Pathol.,
December 1, 2002;
55(12):
926 - 931.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Abramova, J. Parekh, W. P. Irvin Jr, L. W. Rice, P. T. Taylor Jr, W. A. Anderson, and C. L. Slingluff Jr
Sentinel Node Biopsy in Vulvar and Vaginal Melanoma: Presentation of Six Cases and a Literature Review
Ann. Surg. Oncol.,
November 1, 2002;
9(9):
840 - 846.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Taback, K. Hashimoto, C. T. Kuo, A. Chan, A. E. Giuliano, and D. S. B. Hoon
Molecular Lymphatic Mapping of the Sentinel Lymph Node
Am. J. Pathol.,
October 1, 2002;
161(4):
1153 - 1161.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
N. M. Hansen, B. J. Grube, and A. E. Giuliano
The Time Has Come to Change the Algorithm for the Surgical Management of Early Breast Cancer
Arch Surg,
October 1, 2002;
137(10):
1131 - 1135.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morrow, E. A. Strom, L. W. Bassett, D. D. Dershaw, B. Fowble, A. Giuliano, J. R. Harris, F. O'Malley, S. J. Schnitt, S. E. Singletary, et al.
Standard for Breast Conservation Therapy in the Management of Invasive Breast Carcinoma
CA Cancer J Clin,
September 1, 2002;
52(5):
277 - 300.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. C. Paramo, J. Summerall, R. Poppiti, and T. W. Mesko
Validation of Sentinel Node Mapping in Patients With Colon Cancer
Ann. Surg. Oncol.,
July 1, 2002;
9(6):
550 - 554.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. S. Henry-Tillman, S. Korourian, I. T. Rubio, A. T. Johnson, A. T. Mancino, N. Massol, L. F. Smith, K. C. Westbrook, and V. S. Klimberg
Intraoperative Touch Preparation for Sentinel Lymph Node Biopsy: A 4-Year Experience
Ann. Surg. Oncol.,
May 1, 2002;
9(4):
333 - 339.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
V. Stearns, C. A. Ewing, R. Slack, M. F. Penannen, D. F. Hayes, and T. N. Tsangaris
Sentinel Lymphadenectomy After Neoadjuvant Chemotherapy for Breast Cancer May Reliably Represent the Axilla Except for Inflammatory Breast Cancer
Ann. Surg. Oncol.,
April 1, 2002;
9(3):
235 - 242.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. R. Miller, V. E. Thomason, I-T. Yeh, A. Alrahwan, F. E. Sharkey, J. Stauffer, P. M. Otto, C. McKay, M. S. Kahlenberg, W. T. Phillips, et al.
Analysis of Sentinel Lymph Node Mapping With Immediate Pathologic Review in Patients Receiving Preoperative Chemotherapy for Breast Carcinoma
Ann. Surg. Oncol.,
April 1, 2002;
9(3):
243 - 247.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. L. Wong, M. J. Edwards, C. Chao, T. M. Tuttle, R. D. Noyes, D. J. Carlson, A. L. Laidley, T. Q. McGlothin, P. B. Ley, C. M. Brown, et al.
The Effect of Prior Breast Biopsy Method and Concurrent Definitive Breast Procedure on Success and Accuracy of Sentinel Lymph Node Biopsy
Ann. Surg. Oncol.,
April 1, 2002;
9(3):
272 - 277.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Morrow and W. Gradishar
Recent developments: Breast cancer
BMJ,
February 16, 2002;
324(7334):
410 - 414.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. S. Chin and H. D. Bear
Sentinel Node Mapping Identifies Vaccine-Draining Lymph Nodes With Tumor-Specific Immunological Activity
| |